Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma

DOI: 10.1080/2162402X.2018.1500109

Keywords: Cetuximab, Nasopharyngeal carcinoma (NPC), Poly-L-lysine double stranded RNA (Poly-ICLC), polymorphisms, Toll-like receptor 3 (TLR3)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text